4579RaQualia Pharma4579 info
$2.36info-2.37%24h
Global rank23248
Market cap$51.10M
Change 7d-6.80%
YTD Performance-45.02%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    RaQualia Pharma (4579) Stock Overview

    RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products portfolio includes tegoprazan for gastroesophageal reflux disease, which is in phase 3 clinical trial in the United States; and grapiprant for cancer, which is in phase I clinical trial in China and the United States, as well as grapiprant for pain management The company also provides veterinary products, such as grapiprant for osteoarthritis in dogs; ghrelin receptor agonist to treat cancer-related anorexia/cachexia syndrome, and constipation resulting from spinal cord injury; and ELURA, a drug for the management of weight loss in cats with chronic kidney disease. In addition, it provides TRPM8 blocker for the indication of chronic pain; motilin receptor agonist to treat gastrointestinal dysmotility, including gastroparesis, functional dyspepsia, and post-operative ileus; 5-HT4 partial agonist to treat gastroparesis, functional dyspepsia, and chronic constipation; 5-HT2B antagonist to treat irritable bowel syndrome with diarrhea; EP4 antagonist, a pain management drugs for dogs; serotonin 5-HT2A and dopamine D2 receptor blocker to treat schizophrenia; EP4 antagonist to treat cancer that is in phase I clinical trial; Cyclooxygenase-2 inhibitor, which is in phase I clinical trials for the indication of pain; CB2 agonist for pain; selective sodium channel blocker for pain and itch; P2X7 receptor antagonist, which is in Phase 2 clinical trials for the target indication of chronic pain. It has a collaborative agreement with Socium Corporation and Epigeneron, Inc. The company was incorporated in 2008 and is headquartered in Nagoya, Japan.

    4579 Stock Information

    Symbol
    4579
    Address
    Meieki Southside SquareNagoya, 450-0003Japan
    Founded
    -
    Trading hours
    -
    Website
    https://www.raqualia.co.jp
    Country
    🇯🇵 Japan
    Phone Number
    81 52 446 6100

    RaQualia Pharma (4579) Price Chart

    -
    Value:-

    RaQualia Pharma Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.36
    N/A
    Market Cap
    $51.10M
    N/A
    Shares Outstanding
    21.62M
    N/A
    Employees
    65.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org